Health Lev Facher Trump administration’s drug strategy is at odds with recent actions on funding, policy
Biotech Adam Feuerstein STAT Plus: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study
Health Elizabeth Cooney STAT Plus: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows
Health Elizabeth Cooney STAT Plus: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Biotech Adam Feuerstein STAT Plus: Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial
Exclusive Mario Aguilar STAT Plus: Health tech company says it will dive into Medicare’s new chronic care experiment
Health Lev Facher To fix ‘spiritual malaise’ behind addiction, Kennedy announces efforts on homelessness and recovery
Adam's Biotech Scorecard Adam Feuerstein STAT Plus: As FDA raises bar in rare diseases, pivotal moment nears for RegenxBio
Health Elizabeth Cooney Bariatric surgery beats GLP-1s for type 2 diabetes across income levels, study says
Exclusive Isabella Cueto STAT Plus: Behind new dietary guidelines: Industry-funded studies, opaque science, crushing deadline pressure
Biotech Adam Feuerstein STAT Plus: Insmed basks in the success of its lung disease drug — and prepares for what’s next
Health Sarah Todd, Elizabeth Cooney, and Isabella Cueto How saturated fats lost, and won, on new food pyramid
Pharma Elaine Chen STAT Plus: Eli Lilly’s Zepbound, on top of immunology drug, helped reduce psoriatic arthritis symptoms
Exclusive Isabella Cueto and Sarah Todd STAT Plus: Panel behind new dietary guidelines had financial ties to beef, dairy industries
Health Lev Facher Facing federal hostility, supervised consumption site points to 1,900 overdose reversals